According to our latest study on "Clinical Reference Laboratory Market Forecast to 2031 - Global Analysis - by Service Provider and Application" the market was valued at US$ 74.08 billion by 2031 from US$ 45.35 billion in 2023 by 2030. It is estimated to register a CAGR of 6.3% from 2023 to 2031.

The increasing prevalence of chronic diseases and the emergence and outbreak of various infectious diseases have fueled the demand for novel treatment options and newer therapeutic categories and created the need for better treatment options in existing therapeutic categories. According to the WHO data released in September 2023, noncommunicable diseases (NCDs), including heart disease, cancer, stroke, diabetes, and chronic lung disease, kill 41 million people each year. According to the United Health Foundation, more than 29 million US adults reported having three or more chronic conditions in 2022. Accurate diagnostics are critical for identifying disease biomarkers and detecting organisms, particularly in cancer and tuberculosis. Clinical reference laboratories play an important role in modern healthcare. The reference laboratories provide services for the quick diagnosis of infectious diseases that require specialized laboratory testing equipment and expertise, such as swine flu and hepatitis A and B. These laboratories also offer low-cost diagnostic testing for common chronic conditions such as cancer, diabetes, and cardiovascular disease.

During the COVID-19 pandemic, it became evident that medical reference labs are critical for rapid testing, establishing novel techniques, generating and analyzing data, and serving as knowledge hubs. Reference labs are more than just high-volume testing facilities; they are the hubs of expertise and data. Thus, the rising prevalence of infectious and chronic diseases is driving the growth of the clinical reference laboratory market.

By Service Provider, Clinical Reference Laboratory Market-Based Insights

The clinical reference laboratory market, by application, is segmented into hospital-based, standalone, and clinical-based. The hospital-based segment held the largest market share in 2023. The standalone segment is anticipated to register the highest CAGR during 2023-2031. Most hospitals have a laboratory for testing during emergencies. The tests performed by the hospital-based reference laboratory include troponin markers for heart attacks, where findings are needed quickly for patient care, and some tests are done in large volumes, such as electrolytes managed within hospital facilities. Large hospitals may process hundreds of samples.

By Application, Clinical Reference Laboratory Market -Based Insights

In terms of type, the clinical reference laboratory market is segmented into laboratory medicine, clinical trials, and others. The laboratory medicine segment held the largest clinical reference laboratory market share in 2023. The clinical trials segment is anticipated to register the highest CAGR during 2023-2031. Laboratory medicine is essential in healthcare because it provides objective data to help healthcare professionals guide disease prevention, risk assessment, diagnosis, therapy, and patient monitoring, ensuring safe, appropriate, and effective clinical decision-making. The clinical reference laboratory is critical in laboratory medicine management because it provides specialized diagnostic tests and services that normal clinical laboratories are unable to offer. For example, the UC Health Laboratory strives for excellence in laboratory services and offers professional support in laboratory medicine.

Investor Presentation, World Health Organization, and National Institute For Health Research's Clinical Research Network are a few of the major secondary sources referred to while preparing the report on the clinical reference laboratory market.